The Supreme Court of Russia has rejected a lawsuit from US biopharmaceutical company Gilead Sciences (Nasdaq:GILD) challenging the Russian government's decision in 2020 to let Russian pharmaceutical firm Pharmasyntez to develop the COVID-19 drug remdesivir without Gilead's consent, Reuters news agency reported on Thursday.

Reportedly, Pharmasyntez recently shipped a generic version of the drug, called Remdeform, to India as part of humanitarian aid contributions.